Ankyra Therapeutics and Jenga Biosciences Announce Exclusive License Agreement for JEN-101

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 26, 2024--

Related Keywords

Massachusetts ,United States ,Ankyra ,Ankara ,Turkey ,Cambridge ,Cambridgeshire ,United Kingdom ,Howard Kaufman ,Julia Stephanus ,Rob Tighe ,Howardl Kaufman ,Jenga Biosciences , ,Chief Scientific Officer ,Chief Executive Officer ,Executive Chair ,Borealis Ventures ,For Ankyra Media ,Investor Inquiries ,Business Wire ,